Showing results (181-190 of 243) with videos related to
Sort By:
Pageof 25
Plos Neglected Tropical Diseases|November 7, 2014
Topography and land cover of watersheds predicts the distribution of the environmental pathogen Mycobacterium ulcerans in aquatic insectsKevin Carolan, Andres Garchitorena, Gabriel E García-Peña, et al.Journal of Hepatology|February 28, 2016
Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural EgyptAya Mostafa, Yusuke Shimakawa, Ahmed Medhat, et al.Viruses|December 23, 2022
Consequences of In Utero Zika Virus Exposure and Adverse Pregnancy and Early Childhood Outcomes: A Prospective Cohort StudyRebecca Grant, Olivier Flechelles, Narcisse Elenga, et al.Plos One|September 29, 2009
Injection drug use is a risk factor for HCV infection in urban EgyptAdela Paez Jimenez, Mostafa K Mohamed, Noha Sharaf Eldin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Predictors of pneumocystosis or tuberculosis in HIV-infected Asian patients with AFB smear-negative sputum pneumoniaOdile Le Minor, Yves Germani, Loic Chartier, et al.Plos One|September 7, 2017
An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphismsDarragh Duffy, Estelle Mottez, Shaun Ainsworth, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2014
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of EgyptDorothée Obach, Sylvie Deuffic-Burban, Gamal Esmat, et al.BMC Infectious Diseases|July 11, 2006
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control studyJing He, Dan Feng, Sake J de Vlas, et al.Journal of Medical Virology|July 24, 2009
Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4Hesham El Makhzangy, Gamal Esmat, Mohamed Said, et al.The Lancet. Global Health|November 5, 2021
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccinesMiquel Oliu-Barton, Bary S R Pradelski, Yann Algan, et al.Pageof 25